Tadas S. Vasaitis

1.4k total citations
21 papers, 1.1k citations indexed

About

Tadas S. Vasaitis is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Tadas S. Vasaitis has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Tadas S. Vasaitis's work include Prostate Cancer Treatment and Research (14 papers), Estrogen and related hormone effects (11 papers) and Hormonal and reproductive studies (6 papers). Tadas S. Vasaitis is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Estrogen and related hormone effects (11 papers) and Hormonal and reproductive studies (6 papers). Tadas S. Vasaitis collaborates with scholars based in United States, Portugal and Türkiye. Tadas S. Vasaitis's co-authors include Vincent C.O. Njar, Lalji K. Gediya, Robert D. Bruno, Angela Brodie, Pankaj Chopra, Puranik Purushottamachar, Zhiyong Guo, Aakanksha Khandelwal, Venkatesh Handratta and Aashvini Belosay and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Nutrition.

In The Last Decade

Tadas S. Vasaitis

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tadas S. Vasaitis United States	19	525	445	384	307	192	21	1.1k
Masuo Yamaoka Japan	17	351 0.7×	651 1.5×	296 0.8×	413 1.3×	112 0.6×	24	1.0k
Lalji K. Gediya United States	19	773 1.5×	338 0.8×	271 0.7×	195 0.6×	373 1.9×	26	1.3k
Venkatesh Handratta United States	12	435 0.8×	364 0.8×	412 1.1×	180 0.6×	112 0.6×	14	930
Michael L. Mohler United States	19	419 0.8×	295 0.7×	269 0.7×	416 1.4×	218 1.1×	31	1.1k
S. Elaine Barrie United Kingdom	16	564 1.1×	564 1.3×	265 0.7×	362 1.2×	122 0.6×	25	1.3k
Qingzhong Hu Germany	24	337 0.6×	217 0.5×	333 0.9×	546 1.8×	305 1.6×	48	1.3k
Eric Leblanc Canada	21	684 1.3×	679 1.5×	433 1.1×	307 1.0×	152 0.8×	38	1.4k
Leonid Kirkovsky United States	12	186 0.4×	205 0.5×	252 0.7×	352 1.1×	110 0.6×	14	693
Ursula Müller‐Vieira Germany	24	454 0.9×	80 0.2×	292 0.8×	422 1.4×	225 1.2×	29	1.5k
René Maltais Canada	20	599 1.1×	67 0.2×	561 1.5×	349 1.1×	316 1.6×	84	1.1k

Countries citing papers authored by Tadas S. Vasaitis

Since Specialization

Citations

This map shows the geographic impact of Tadas S. Vasaitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadas S. Vasaitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadas S. Vasaitis more than expected).

Fields of papers citing papers by Tadas S. Vasaitis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadas S. Vasaitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadas S. Vasaitis. The network helps show where Tadas S. Vasaitis may publish in the future.

Co-authorship network of co-authors of Tadas S. Vasaitis

This figure shows the co-authorship network connecting the top 25 collaborators of Tadas S. Vasaitis. A scholar is included among the top collaborators of Tadas S. Vasaitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadas S. Vasaitis. Tadas S. Vasaitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Yan, Adrienne N. Poon, Wen-Chih Wu, et al.. (2024). Heart Failure Among Asian American Subpopulations. JAMA Network Open. 7(9). e2435672–e2435672. 3 indexed citations

Ramalingam, Senthilmurugan, Vidya P. Ramamurthy, Lalji K. Gediya, et al.. (2019). The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis. Cancers. 11(3). 299–299. 26 indexed citations

Sorkin, John D., Tadas S. Vasaitis, Elizabeth A. Streeten, Alice S. Ryan, & Andrew P. Goldberg. (2014). Evidence for Threshold Effects of 25-Hydroxyvitamin D on Glucose Tolerance and Insulin Resistance in Black and White Obese Postmenopausal Women. Journal of Nutrition. 144(5). 734–742. 34 indexed citations

Tilghman, Syreeta L., Lyndsay V. Rhodes, Melyssa R. Bratton, et al.. (2013). Phytoalexins, miRNAs and Breast Cancer: A Review of Phytochemical-mediated miRNA Regulation in Breast Cancer. Journal of Health Care for the Poor and Underserved. 24(1A). 36–46. 21 indexed citations

Purushottamachar, Puranik, Lalji K. Gediya, Tadas S. Vasaitis, et al.. (2013). Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer. Journal of Medicinal Chemistry. 56(12). 4880–4898. 83 indexed citations

Moreira, Vânia M., Jorge A. R. Salvador, Α. Matos Beja, et al.. (2011). C16 and C17-heterocycle bearing androstanes. CYP17 inhibition studies and multiple effects on prostate cancer cells. European Journal of Pharmaceutical Sciences. 44. 2 indexed citations

Bruno, Robert D., Tadas S. Vasaitis, Lalji K. Gediya, et al.. (2011). Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): Head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model. Steroids. 76(12). 1268–1279. 57 indexed citations

Vasaitis, Tadas S., Robert D. Bruno, & Vincent C.O. Njar. (2010). CYP17 inhibitors for prostate cancer therapy. The Journal of Steroid Biochemistry and Molecular Biology. 125(1-2). 23–31. 161 indexed citations

Vasaitis, Tadas S. & Vincent C.O. Njar. (2010). Novel, Potent Anti-Androgens of Therapeutic Potential: Recent Advances and Promising Developments. Future Medicinal Chemistry. 2(4). 667–680. 28 indexed citations

10.

Purushottamachar, Puranik, Aakanksha Khandelwal, Tadas S. Vasaitis, et al.. (2008). Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent. Bioorganic & Medicinal Chemistry. 16(7). 3519–3529. 26 indexed citations

11.

Vasaitis, Tadas S., Aashvini Belosay, Adam Schayowitz, et al.. (2008). Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. Molecular Cancer Therapeutics. 7(8). 2348–2357. 111 indexed citations

12.

Moreira, Vânia M., Tadas S. Vasaitis, Zhiyong Guo, Vincent C.O. Njar, & Jorge A. R. Salvador. (2008). Synthesis of novel C17 steroidal carbamates. Steroids. 73(12). 1217–1227. 23 indexed citations

13.

Brodie, Angela, Vincent C.O. Njar, Luciana F. Macedo, Tadas S. Vasaitis, & Gauri Sabnis. (2008). The Coffey Lecture: Steroidogenic enzyme inhibitors and hormone dependent cancer. Urologic Oncology Seminars and Original Investigations. 27(1). 53–63. 21 indexed citations

14.

Moreira, Vânia M., Jorge A. R. Salvador, Tadas S. Vasaitis, & Vincent C.O. Njar. (2008). CYP17 Inhibitors for Prostate Cancer Treatment – An Update. Current Medicinal Chemistry. 15(9). 868–899. 31 indexed citations

15.

Moreira, Vânia M., Tadas S. Vasaitis, Vincent C.O. Njar, & Jorge A. R. Salvador. (2007). Synthesis and evaluation of novel 17-indazole androstene derivatives designed as CYP17 inhibitors. Steroids. 72(14). 939–948. 36 indexed citations

16.

Purushottamachar, Puranik, Aakanksha Khandelwal, Pankaj Chopra, et al.. (2007). First pharmacophore-based identification of androgen receptor down-regulating agents: Discovery of potent anti-prostate cancer agents. Bioorganic & Medicinal Chemistry. 15(10). 3413–3421. 19 indexed citations

17.

Njar, Vincent C.O., Lalji K. Gediya, Puranik Purushottamachar, et al.. (2006). Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorganic & Medicinal Chemistry. 14(13). 4323–4340. 117 indexed citations

18.

Handratta, Venkatesh, Tadas S. Vasaitis, Vincent C.O. Njar, et al.. (2005). Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, in Vitro Biological Activity, Pharmacokinetics, and Antitumor Activity in the LAPC4 Human Prostate Cancer Xenograft Model. Journal of Medicinal Chemistry. 48(8). 2972–2984. 209 indexed citations

19.

Wang, Qianben, et al.. (2004). Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells. Journal of Biological Chemistry. 279(17). 17319–17328. 40 indexed citations

20.

Clement, Omoshile, C. M. Freeman, Rolf W. Hartmann, et al.. (2003). Three Dimensional Pharmacophore Modeling of Human CYP17 Inhibitors. Potential Agents for Prostate Cancer Therapy. Journal of Medicinal Chemistry. 46(12). 2345–2351. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact